UBS Initiates Coverage of Core Scientific with Buy
Fintel reports that on September 23, 2026, UBS initiated coverage of Core Scientific (NASDAQGS:CORZ) (BIT:1CORZ) with a Buy recommendation.
This initiation follows other recent analyst actions for the company. On September 21, 2026, Rothschild & Co initiated coverage of Core Scientific with a Neutral rating. Prior to that, on September 17, 2026, Wells Fargo initiated coverage with an Overweight rating. The stock closed at $18.79 on September 22, 2026, the session prior to the UBS action. This closing price represents a +17.14% change over the preceding week, compared to a baseline close of $16.04 on September 15, 2026. Over a longer one-month timeframe, the stock has experienced a +5.50% change from its baseline close of $17.81 on August 21, 2026.
Separately, the broader consensus target price for Core Scientific was recorded at a mean of $35.71 and a median of $35.70 as of September 15, 2026. This mean target represents an implied change of +90.02% from the stock's recent levels. The consensus target mean was unchanged from the prior mean of $35.71 recorded on August 28, 2026, representing a revision percent of 0.00%.
In its latest quarterly financial results reported on July 28, 2026, Core Scientific posted an actual EPS of -3.13, compared to the analyst estimate of -0.0718. The company generated actual revenue of $164,201,000.00, which exceeded the estimated revenue of $145,842,364.00. The company's upcoming earnings announcement is scheduled for October 22, 2026.
According to recommendation data as of September 1, 2026, the aggregate analyst sentiment shows a total of 26 recommendations, consisting of 7 strong buy, 16 buy, 3 hold, 0 sell, and 0 strong sell ratings. This distribution results in a positive recommendation percentage of 88.5% and a hold percentage of 11.5%. These figures are identical to the prior recommendation period recorded on August 1, 2026, which also reported 26 total recommendations with the same breakdown of 7 strong buy, 16 buy, and 3 hold ratings.
Recent analyst actions
| Date | Analyst | Prior | Latest recommendation | Action |
|---|---|---|---|---|
| September 23, 2026 | UBS | Buy | initiated coverage | |
| September 21, 2026 | Rothschild & Co | Neutral | initiated coverage | |
| September 17, 2026 | Wells Fargo | Overweight | initiated coverage |
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.